[Fibrogenesis. Pathophysiology and therapeutic approaches].
Knittel
T
T
Abteilung Gastroenterologie und Endokrinologie, Zentrum Innere Medizin, Universitätsklinik Göttingen.
Saile
B
B
Ramadori
G
G
D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D017364:Collagenases / Q000502:physiology; D003238:Connective Tissue / Q000187:drug effects / Q000503:physiopathology; D005109:Extracellular Matrix / Q000187:drug effects / Q000502:physiology; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007728:Kupffer Cells / Q000187:drug effects / Q000502:physiology; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000503:physiopathology*; D020781:Matrix Metalloproteinase 1; D013234:Stem Cells / Q000187:drug effects / Q000502:physiology; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000502:physiology
D019715:Tissue Inhibitor of Metalloproteinase-1; D016212:Transforming Growth Factor beta; D017364:Collagenases; D020781:Matrix Metalloproteinase 1